Actinium Pharmaceuticals (ATNM) Notes Payables (2011 - 2024)
Actinium Pharmaceuticals' Short-Term Borrowings came in at $7.51 million for Q1 2024, up 2.1% from $7.36 million a year earlier but down 5.5% from the prior quarter.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Notes Payables (2011 - 2024) Analysis & Trends
At the end of FY2023, Actinium Pharmaceuticals' Short-Term Borrowings was $7.95 million, down 21.5% from FY2022.
- Short-Term Borrowings carries a five-year compound annual growth rate of 99.9% (FY2018 to FY2023).
- Going back by year, Short-Term Borrowings was $10.13 million in FY2022 (+83.0%), $5.54 million in FY2021 (+27.5%), $4.34 million in FY2020 and $381,000 in FY2019 (+52.9%).
- The five-year range for quarterly Short-Term Borrowings is $25,331 (Q3 2019) to $10.13 million (Q4 2022).
- Year-over-year, Short-Term Borrowings increased in seven of the last eight quarters, with growth averaging 41.7%.
- The fastest year-over-year change in Short-Term Borrowings over five years came in Q3 2022 (growth of 108.6%), and the weakest in Q4 2023 (a decline of 21.5%).
- Business Quant data shows ATNM's Short-Term Borrowings at $7.95 million (Q4 2023), $8.15 million (Q3 2023) and $8.64 million (Q2 2023) in the three quarters before Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Actinium Pharmaceuticals | 49.05 Mn | -130.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 7.51 Mn |
| Dec 31, 2023 | 7.95 Mn |
| Sep 30, 2023 | 8.15 Mn |
| Jun 30, 2023 | 8.64 Mn |
| Mar 31, 2023 | 7.36 Mn |
| Dec 31, 2022 | 10.13 Mn |
| Sep 30, 2022 | 7.87 Mn |
| Jun 30, 2022 | 5.77 Mn |
| Mar 31, 2022 | 5.26 Mn |
| Dec 31, 2021 | 5.54 Mn |
| Sep 30, 2021 | 3.77 Mn |
| Jun 30, 2021 | 3.43 Mn |
| Mar 31, 2021 | 3.73 Mn |
| Dec 31, 2020 | 4.34 Mn |
| Sep 30, 2020 | 38,000.00 |
| Jun 30, 2020 | 154,000.00 |
| Mar 31, 2020 | 268,000.00 |
| Dec 31, 2019 | 381,000.00 |
| Sep 30, 2019 | 25,331.00 |
| Jun 30, 2019 | 100,777.00 |
API Access
Actinium Pharmaceuticals Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();